FDA takes more time for cough/cold amendment
This article was originally published in The Tan Sheet
Executive SummaryFDA pushes back the targets dates for a proposed amendment to the cough/cold monograph from June to December 2010 and a final OTC monograph rule from May to October 2010, according to the Department of Health and Human Services' semi-annual regulatory 1agenda published April 26. FDA said in August 2008 it would propose revised labeling under the current final cough/cold monograph in response to concerns about pediatric cough and cold products (2"The Tan Sheet" Aug. 25, 2008). FDA's final monograph for sunscreens emerged in 1999, but industry pressure consistently has stayed its publication
You may also be interested in...
Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus situation in China, generics industry leader Mylan came under pressure about the potential impact on its business.
Government advisory committee gives initial nod to what will become Japan’s most expensive single drug, but reimbursement pricing could come in for close scrutiny.